CCL2 and supranuclear palsy, progressive, 1: Additionally, plasma inflammatory biomarkers such as IL-6, TNFα, IL-1 β, CXCL10, MCP-1, and CRP are elevated in PSP patients, indicating ongoing systemic inflammation in PSP [71].